Table 1.
Baseline characteristics of hospitalized patients between 23 February and 14 May.
Year 2019 | Year 2020 | p-Value | COVID-19 2020 | Non-COVID-19 2020 | p-Value | |
---|---|---|---|---|---|---|
(n = 8656) | (n = 7938) | (n = 4160) | (n = 3778) | |||
Age | ||||||
Median (IQR) | 61 (33–78) | 64 (35–79) | <0.001 Ɨ | 73 (59–82) | 39 (11–71) | <0.001 Ɨ |
Class | ||||||
0 | 717 (8.3%) | 831 (10.5%) | <0.001 | 44 (1.1%) | 787 (20.8%) | <0.001 |
1–17 | 753 (8.7%) | 356 (4.5%) | <0.001 | 132 (3.2%) | 224 (5.9%) | <0.001 |
18–39 | 1171 (13.5%) | 1075 (13.5%) | 0.99 | 180 (4.3%) | 895 (23.7%) | <0.001 |
40–64 | 2005 (23.2%) | 1701 (21.4%) | 0.007 | 1040 (25.0%) | 661 (17.5%) | <0.001 |
65–80 | 2090 (24.1%) | 1969 (24.8%) | 0.67 | 1337 (32.1%) | 632 (16.7%) | <0.001 |
80 + | 1919 (22.2%) | 1940 (24.4%) | <0.001 | 1361 (32.7%) | 579 (15.3%) | <0.001 |
Sex | ||||||
F | 4443 (51.3%) | 4023 (50.7%) | 0.41 | 1807 (43.4%) | 2216 (58.7%) | <0.001 |
M | 4212 (48.7%) | 3915 (49.3%) | 0.41 | 2353 (56.6%) | 1562 (41.3%) | <0.001 |
Comorbidities | ||||||
Median (IQR) | 2 (1–4) | 4 (2–6) | <0.001 Ɨ | 4 (3–6) | 2 (1–4) | <0.001 Ɨ |
Acute NCDs | ||||||
Acute Myocardial Infarction | 230 (2.7%) | 152 (1.9%) | 0.002 | 73 (1.8%) | 79 (2.1%) | 0.32 |
Cerebrovascular Disease (Stroke, TIA) | 566 (6.5%) | 331 (4.2%) | <0.001 | 178 (4.3%) | 153 (4.0%) | 0.65 |
Chronic NCDs | ||||||
Hypertension | 1420 (16.4%) | 1360 (17.1%) | 0.21 | 993 (23.9%) | 367 (9.7%) | <0.001 |
Dementia | 409 (4.7%) | 328 (4.1%) | 0.07 | 253 (6.1%) | 75 (2.0%) | <0.001 |
Chronic Respiratory Disease (COPD, Asthma) | 418 (4.8%) | 334 (4.2%) | 0.6 | 246 (5.9%) | 88 (2.3%) | <0.001 |
Diabetes | 751 (8.7%) | 684 (8.6%) | 0.9 | 495 (11.9%) | 189 (5%) | <0.001 |
Cancer | 1152 (13.3%) | 784 (9.9%) | <0.001 | 326 (7.8%) | 458 (12.1%) | <0.001 |
Urgent surgical procedures | ||||||
257(3%) | 160(2%) | <0.001 | 82 (2%) | 78 (2.1%) | 0.8 |
Ɨ p-value obtained by means of Mann–Whitney Test. No correction for multiple testing was applied. TIA, Transient Ischemic Attack.